Global Metabotropic Glutamate Receptor 2 Market Growth 2025-2031

January 2025 | 105 pages | ID: G448E30FAAC5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Metabotropic Glutamate Receptor 2 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Metabotropic Glutamate Receptor 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Metabotropic Glutamate Receptor 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Metabotropic Glutamate Receptor 2 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Metabotropic Glutamate Receptor 2 players cover Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Metabotropic Glutamate Receptor 2 Industry Forecast” looks at past sales and reviews total world Metabotropic Glutamate Receptor 2 sales in 2024, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 2 sales for 2025 through 2031. With Metabotropic Glutamate Receptor 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 2 industry.

This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metabotropic Glutamate Receptor 2 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 2.

This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 2 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• LY-2607540
• BMT-133218
• DT-2442
• JNJ-40411813
• Others

Segmentation by Application:

• Anxiety Disorders
• Depression
• Schizophrenia
• Chronic Pain
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Addex Therapeutics Ltd
• Bristol-Myers Squibb Company
• Denovo Biopharma LLC
• Domain Therapeutics SA
• Eli Lilly and Company
• Johnson & Johnson
• Merck & Co Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Metabotropic Glutamate Receptor 2 market?

What factors are driving Metabotropic Glutamate Receptor 2 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Metabotropic Glutamate Receptor 2 market opportunities vary by end market size?

How does Metabotropic Glutamate Receptor 2 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Country/Region, 2020, 2024 & 2031
2.2 Metabotropic Glutamate Receptor 2 Segment by Type
  2.2.1 LY-2607540
  2.2.2 BMT-133218
  2.2.3 DT-2442
  2.2.4 JNJ-40411813
  2.2.5 Others
2.3 Metabotropic Glutamate Receptor 2 Sales by Type
  2.3.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2020-2025)
  2.3.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2020-2025)
2.4 Metabotropic Glutamate Receptor 2 Segment by Application
  2.4.1 Anxiety Disorders
  2.4.2 Depression
  2.4.3 Schizophrenia
  2.4.4 Chronic Pain
  2.4.5 Others
2.5 Metabotropic Glutamate Receptor 2 Sales by Application
  2.5.1 Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2020-2025)
  2.5.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Metabotropic Glutamate Receptor 2 Breakdown Data by Company
  3.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Company (2020-2025)
  3.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2020-2025)
3.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Company (2020-2025)
  3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Company (2020-2025)
  3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2020-2025)
3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 2 Product Location Distribution
  3.4.2 Players Metabotropic Glutamate Receptor 2 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION

4.1 World Historic Metabotropic Glutamate Receptor 2 Market Size by Geographic Region (2020-2025)
  4.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Metabotropic Glutamate Receptor 2 Market Size by Country/Region (2020-2025)
  4.2.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Metabotropic Glutamate Receptor 2 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 2 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 2 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Growth

5 AMERICAS

5.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country
  5.1.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025)
  5.1.2 Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025)
5.2 Americas Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
5.3 Americas Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region
  6.1.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025)
  6.1.2 APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025)
6.2 APAC Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
6.3 APAC Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Metabotropic Glutamate Receptor 2 by Country
  7.1.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025)
  7.1.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025)
7.2 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
7.3 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metabotropic Glutamate Receptor 2 by Country
  8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
8.3 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 2 Distributors
11.3 Metabotropic Glutamate Receptor 2 Customer

12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION

12.1 Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Region
  12.1.1 Global Metabotropic Glutamate Receptor 2 Forecast by Region (2026-2031)
  12.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Metabotropic Glutamate Receptor 2 Forecast by Type (2026-2031)
12.7 Global Metabotropic Glutamate Receptor 2 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Addex Therapeutics Ltd
  13.1.1 Addex Therapeutics Ltd Company Information
  13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Addex Therapeutics Ltd Main Business Overview
  13.1.5 Addex Therapeutics Ltd Latest Developments
13.2 Bristol-Myers Squibb Company
  13.2.1 Bristol-Myers Squibb Company Company Information
  13.2.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bristol-Myers Squibb Company Main Business Overview
  13.2.5 Bristol-Myers Squibb Company Latest Developments
13.3 Denovo Biopharma LLC
  13.3.1 Denovo Biopharma LLC Company Information
  13.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Denovo Biopharma LLC Main Business Overview
  13.3.5 Denovo Biopharma LLC Latest Developments
13.4 Domain Therapeutics SA
  13.4.1 Domain Therapeutics SA Company Information
  13.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Domain Therapeutics SA Main Business Overview
  13.4.5 Domain Therapeutics SA Latest Developments
13.5 Eli Lilly and Company
  13.5.1 Eli Lilly and Company Company Information
  13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Eli Lilly and Company Main Business Overview
  13.5.5 Eli Lilly and Company Latest Developments
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Information
  13.6.2 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Johnson & Johnson Main Business Overview
  13.6.5 Johnson & Johnson Latest Developments
13.7 Merck & Co Inc
  13.7.1 Merck & Co Inc Company Information
  13.7.2 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
  13.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Merck & Co Inc Main Business Overview
  13.7.5 Merck & Co Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of LY-2607540
Table 4. Major Players of BMT-133218
Table 5. Major Players of DT-2442
Table 6. Major Players of JNJ-40411813
Table 7. Major Players of Others
Table 8. Global Metabotropic Glutamate Receptor 2 Sales byType (2020-2025) & (K Pcs)
Table 9. Global Metabotropic Glutamate Receptor 2 Sales Market Share byType (2020-2025)
Table 10. Global Metabotropic Glutamate Receptor 2 Revenue byType (2020-2025) & ($ million)
Table 11. Global Metabotropic Glutamate Receptor 2 Revenue Market Share byType (2020-2025)
Table 12. Global Metabotropic Glutamate Receptor 2 Sale Price byType (2020-2025) & (USD/Pcs)
Table 13. Global Metabotropic Glutamate Receptor 2 Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2020-2025)
Table 15. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2020-2025) & ($ million)
Table 16. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2020-2025)
Table 17. Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Metabotropic Glutamate Receptor 2 Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2020-2025)
Table 20. Global Metabotropic Glutamate Receptor 2 Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2020-2025)
Table 22. Global Metabotropic Glutamate Receptor 2 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution and Sales Area
Table 24. Players Metabotropic Glutamate Receptor 2 Products Offered
Table 25. Metabotropic Glutamate Receptor 2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 2 Sales Market Share Geographic Region (2020-2025)
Table 30. Global Metabotropic Glutamate Receptor 2 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Metabotropic Glutamate Receptor 2 Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2020-2025)
Table 34. Global Metabotropic Glutamate Receptor 2 Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2025)
Table 38. Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Metabotropic Glutamate Receptor 2 Sales byType (2020-2025) & (K Pcs)
Table 40. Americas Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2020-2025)
Table 43. APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Metabotropic Glutamate Receptor 2 Sales byType (2020-2025) & (K Pcs)
Table 45. APAC Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Metabotropic Glutamate Receptor 2 Sales byType (2020-2025) & (K Pcs)
Table 49. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales byType (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 2
Table 55. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 2
Table 56. Key IndustryTrends of Metabotropic Glutamate Receptor 2
Table 57. Metabotropic Glutamate Receptor 2 Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Metabotropic Glutamate Receptor 2 Distributors List
Table 60. Metabotropic Glutamate Receptor 2 Customer List
Table 61. Global Metabotropic Glutamate Receptor 2 SalesForecast by Region (2026-2031) & (K Pcs)
Table 62. Global Metabotropic Glutamate Receptor 2 RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Metabotropic Glutamate Receptor 2 SalesForecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Metabotropic Glutamate Receptor 2 Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Metabotropic Glutamate Receptor 2 SalesForecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Metabotropic Glutamate Receptor 2 Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Metabotropic Glutamate Receptor 2 SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Metabotropic Glutamate Receptor 2 RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Metabotropic Glutamate Receptor 2 SalesForecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Metabotropic Glutamate Receptor 2 RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Metabotropic Glutamate Receptor 2 SalesForecast byType (2026-2031) & (K Pcs)
Table 72. Global Metabotropic Glutamate Receptor 2 RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Metabotropic Glutamate Receptor 2 SalesForecast by Application (2026-2031) & (K Pcs)
Table 74. Global Metabotropic Glutamate Receptor 2 RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. AddexTherapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 76. AddexTherapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 77. AddexTherapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AddexTherapeutics Ltd Main Business
Table 79. AddexTherapeutics Ltd Latest Developments
Table 80. Bristol-Myers Squibb Company Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 82. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Bristol-Myers Squibb Company Main Business
Table 84. Bristol-Myers Squibb Company Latest Developments
Table 85. Denovo Biopharma LLC Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 86. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 87. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Denovo Biopharma LLC Main Business
Table 89. Denovo Biopharma LLC Latest Developments
Table 90. DomainTherapeutics SA Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 91. DomainTherapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 92. DomainTherapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. DomainTherapeutics SA Main Business
Table 94. DomainTherapeutics SA Latest Developments
Table 95. Eli Lilly and Company Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 96. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 97. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Eli Lilly and Company Main Business
Table 99. Eli Lilly and Company Latest Developments
Table 100. Johnson & Johnson Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 101. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 102. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
Table 105. Merck & Co Inc Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 107. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Merck & Co Inc Main Business
Table 109. Merck & Co Inc Latest Developments



LIST OFFIGURES

Figure 1. Picture of Metabotropic Glutamate Receptor 2
Figure 2. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2024)
Figure 10. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of LY-2607540
Figure 12. Product Picture of BMT-133218
Figure 13. Product Picture of DT-2442
Figure 14. Product Picture of JNJ-40411813
Figure 15. Product Picture of Others
Figure 16. Global Metabotropic Glutamate Receptor 2 Sales Market Share byType in 2025
Figure 17. Global Metabotropic Glutamate Receptor 2 Revenue Market Share byType (2020-2025)
Figure 18. Metabotropic Glutamate Receptor 2 Consumed in Anxiety Disorders
Figure 19. Global Metabotropic Glutamate Receptor 2 Market: Anxiety Disorders (2020-2025) & (K Pcs)
Figure 20. Metabotropic Glutamate Receptor 2 Consumed in Depression
Figure 21. Global Metabotropic Glutamate Receptor 2 Market: Depression (2020-2025) & (K Pcs)
Figure 22. Metabotropic Glutamate Receptor 2 Consumed in Schizophrenia
Figure 23. Global Metabotropic Glutamate Receptor 2 Market: Schizophrenia (2020-2025) & (K Pcs)
Figure 24. Metabotropic Glutamate Receptor 2 Consumed in Chronic Pain
Figure 25. Global Metabotropic Glutamate Receptor 2 Market: Chronic Pain (2020-2025) & (K Pcs)
Figure 26. Metabotropic Glutamate Receptor 2 Consumed in Others
Figure 27. Global Metabotropic Glutamate Receptor 2 Market: Others (2020-2025) & (K Pcs)
Figure 28. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2024)
Figure 29. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application in 2025
Figure 30. Metabotropic Glutamate Receptor 2 Sales by Company in 2025 (K Pcs)
Figure 31. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2025
Figure 32. Metabotropic Glutamate Receptor 2 Revenue by Company in 2025 ($ millions)
Figure 33. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company in 2025
Figure 34. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Metabotropic Glutamate Receptor 2 Sales 2020-2025 (K Pcs)
Figure 37. Americas Metabotropic Glutamate Receptor 2 Revenue 2020-2025 ($ millions)
Figure 38. APAC Metabotropic Glutamate Receptor 2 Sales 2020-2025 (K Pcs)
Figure 39. APAC Metabotropic Glutamate Receptor 2 Revenue 2020-2025 ($ millions)
Figure 40. Europe Metabotropic Glutamate Receptor 2 Sales 2020-2025 (K Pcs)
Figure 41. Europe Metabotropic Glutamate Receptor 2 Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales 2020-2025 (K Pcs)
Figure 43. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue 2020-2025 ($ millions)
Figure 44. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2025
Figure 45. Americas Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2025)
Figure 46. Americas Metabotropic Glutamate Receptor 2 Sales Market Share byType (2020-2025)
Figure 47. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Figure 48. United States Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region in 2025
Figure 53. APAC Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2020-2025)
Figure 54. APAC Metabotropic Glutamate Receptor 2 Sales Market Share byType (2020-2025)
Figure 55. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Figure 56. China Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 60. India Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 62. ChinaTaiwan Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2025
Figure 64. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2025)
Figure 65. Europe Metabotropic Glutamate Receptor 2 Sales Market Share byType (2020-2025)
Figure 66. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Figure 67. Germany Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 68.France Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share byType (2020-2025)
Figure 74. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Figure 75. Egypt Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 78.Turkey Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Metabotropic Glutamate Receptor 2 Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 2 in 2025
Figure 81. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2
Figure 82. Industry Chain Structure of Metabotropic Glutamate Receptor 2
Figure 83. Channels of Distribution
Figure 84. Global Metabotropic Glutamate Receptor 2 Sales MarketForecast by Region (2026-2031)
Figure 85. Global Metabotropic Glutamate Receptor 2 Revenue Market ShareForecast by Region (2026-2031)
Figure 86. Global Metabotropic Glutamate Receptor 2 Sales Market ShareForecast byType (2026-2031)
Figure 87. Global Metabotropic Glutamate Receptor 2 Revenue Market ShareForecast byType (2026-2031)
Figure 88. Global Metabotropic Glutamate Receptor 2 Sales Market ShareForecast by Application (2026-2031)
Figure 89. Global Metabotropic Glutamate Receptor 2 Revenue Market ShareForecast by Application (2026-2031)